Auris Nasus Larynx

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

所有作者均应满足ICMJE作者身份标准，包括对工作构思或设计、数据获取、分析或解释作出实质性贡献，起草或批判性修改稿件，最终批准发表版本，并同意对工作的各个方面负责。 模型中文摘要

All authors should have made substantial contributions to all of the following: 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; 2) Drafting the work or revising it critically for important intellectual content; 3) Final approval of the version to be published; 4) Agreement to be accountable for all aspects …

所有作者必须披露可能不当影响或偏袒其工作的与他人或组织的任何财务和个人关系，包括雇佣、咨询、持股、酬金、有偿专家证言、专利申请或注册、资助以及其他资助等潜在竞争利益。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: Employment Consultancies Stock ownership Honoraria Paid expert testimony Patent applications or registrations Grants or any other funding Affiliation with the journal as an Editor or Advisor…

涉及人类受试者的研究必须符合世界医学协会《赫尔辛基宣言》伦理准则，作者须在方法部分声明研究方案已获机构审查委员会批准，并已获得每位参与者或其监护人的书面知情同意。 模型中文摘要

Any investigation on human subjects must be in accordance with the Code of Ethics of the World Medical Association (Helsinki Declaration). Auris Nasus Larynx requires authors to state in the Method section that the protocol of the investigation has been approved by the Institutional Review Board, and that the investigators have obtained written informed consent from each participant or each partic…

投稿即表示文章为原创且未同时投给其他期刊，文章被接受后作者将被要求将版权转让给出版商。 模型中文摘要

Submission of an article is understood to imply that the article is original and is not being considered for publication elsewhere. Upon acceptance of the article by the journal, the author(s) will be asked to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible dissemination of information.

有关本期刊开放获取出版的更多信息，请访问开放获取页面。 模型中文摘要

Please visit our Open Access page for more information about open access publishing in this journal.

本期刊采用双盲同行评审流程，合适的稿件通常至少送交两名独立专家评审，编辑对稿件接受或拒绝拥有最终决定权。 模型中文摘要

This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

预印本可随时在任何地方共享，符合爱思唯尔的共享政策，在预印本服务器上共享预印本不计作先前发表。 模型中文摘要

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

任何临床试验必须在公开可访问的数据库中注册。 模型中文摘要

Any clinical trial must be registered in a publicly accessible database.